{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:18:52Z","timestamp":1791872332771,"version":"4.3.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94725-4","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:15:10Z","timestamp":1742958910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Omics for searching plasma biomarkers associated with unfavorable COVID-19 progression in hypertensive patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Alba","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciano","family":"Garc\u00eda-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"G\u00f3mez-Bertomeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chafino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Massanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Flores-Pi\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia","family":"Ced\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Peraire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"94725_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. F., Xu, W. & Liu, S. W. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 41, 1141\u20131149 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"94725_CR2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/FJC.0000000000001116","volume":"78","author":"M Peng","year":"2021","unstructured":"Peng, M. et al. Role of hypertension on the severity of COVID-19: A review. J. Cardiovasc. Pharmacol. 78, 648\u2013655 (2021).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"94725_CR3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/bib\/bbaa426","volume":"22","author":"A Nashiry","year":"2021","unstructured":"Nashiry, A., Sarmin Sumi, S., Islam, S., Quinn, J. M. W. & Moni, M. A. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities. Brief. Bioinform. 22, 1387\u20131401 (2021).","journal-title":"Brief. Bioinform."},{"key":"94725_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41371-022-00716-7","volume":"37","author":"S Nakhaie","year":"2023","unstructured":"Nakhaie, S. et al. The effects of antihypertensive medications on severity and outcomes of hypertensive patients with COVID-19. J. Hum. Hypertens. 37, 511\u2013518 (2023).","journal-title":"J. Hum. Hypertens."},{"key":"94725_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"94725_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41440-020-0485-2","volume":"43","author":"S Huang","year":"2020","unstructured":"Huang, S. et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens. Res. 43, 824\u2013831 (2020).","journal-title":"Hypertens. Res."},{"key":"94725_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/jch.13925","volume":"22","author":"M Tadic","year":"2020","unstructured":"Tadic, M., Cuspidi, C., Grassi, G. & Mancia, G. COVID-19 and arterial hypertension: Hypothesis or evidence?. J. Clin. Hypertens. 22, 1120\u20131126 (2020).","journal-title":"J. Clin. Hypertens."},{"key":"94725_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9103136","volume":"9","author":"E Rodilla","year":"2020","unstructured":"Rodilla, E. et al. Association of hypertension with all-cause mortality among hospitalized patients with COVID-19. J. Clin. Med. 9, 1\u201312 (2020).","journal-title":"J. Clin. Med."},{"key":"94725_CR9","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1038\/s41440-024-01772-x","volume":"47","author":"T Okumura","year":"2024","unstructured":"Okumura, T. & Murohara, T. The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks. Hypertens. Res. 47, 2598\u20132600 (2024).","journal-title":"Hypertens. Res."},{"key":"94725_CR10","first-page":"200121","volume":"11","author":"GES Batiha","year":"2021","unstructured":"Batiha, G. E. S. et al. Hypertension and its management in COVID-19 patients: The assorted view. Int. J. Cardiol. Cardiovasc. Risk Prev. 11, 200121 (2021).","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"94725_CR11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00210-021-02147-6","volume":"394","author":"H Onohuean","year":"2021","unstructured":"Onohuean, H. et al. Covid-19 and development of heart failure: mystery and truth Naunyn. Schmiedebergs. Arch. Pharmacol. 394, 2013\u20132021 (2021).","journal-title":"Arch. Pharmacol."},{"key":"94725_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.11606\/s1518-8787.2022056004311","volume":"56","author":"AC Ribeiro","year":"2022","unstructured":"Ribeiro, A. C. & Uehara, S. C. D. S. A. Systemic arterial hypertension as a risk factor for the severe form of covid-19: scoping review. Rev. Saude Publica 56, 20 (2022).","journal-title":"Rev. Saude Publica"},{"key":"94725_CR13","doi-asserted-by":"publisher","first-page":"607647","DOI":"10.3389\/fped.2020.607647","volume":"8","author":"M Samprathi","year":"2021","unstructured":"Samprathi, M. & Jayashree, M. Biomarkers in COVID-19: An up-to-date review. Front. Pediatr. 8, 607647 (2021).","journal-title":"Front. Pediatr."},{"key":"94725_CR14","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/heartjnl-2020-317322","volume":"106","author":"GG Stefanini","year":"2020","unstructured":"Stefanini, G. G. et al. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart 106, 1512\u20131518 (2020).","journal-title":"Heart"},{"key":"94725_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.120.15528","volume":"76","author":"JJ Qin","year":"2020","unstructured":"Qin, J. J. et al. Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19. Hypertension 76, 1104\u20131112 (2020).","journal-title":"Hypertension"},{"key":"94725_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10517-022-05581-5","volume":"173","author":"DS Shilin","year":"2022","unstructured":"Shilin, D. S. & Shapovalov, K. G. Changes in some vascular biomarkers in patients with severe COVID-19 with various degrees of pulmonary hypertension. Bull. Exp. Biol. Med. 173, 433\u2013436 (2022).","journal-title":"Bull. Exp. Biol. Med."},{"key":"94725_CR17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/21505594.2022.2092941","volume":"13","author":"J Ma","year":"2022","unstructured":"Ma, J., Deng, Y., Zhang, M. & Yu, J. The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets. Virulence 13, 1101\u20131110 (2022).","journal-title":"Virulence"},{"key":"94725_CR18","doi-asserted-by":"publisher","first-page":"107948","DOI":"10.1016\/j.isci.2023.107948","volume":"26","author":"A S\u00e1nchez","year":"2023","unstructured":"S\u00e1nchez, A. et al. Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery. iScience 26, 107948 (2023).","journal-title":"iScience"},{"key":"94725_CR19","doi-asserted-by":"publisher","first-page":"e704","DOI":"10.1002\/ctm2.704","volume":"12","author":"L Revert\u00e9","year":"2022","unstructured":"Revert\u00e9, L. et al. Fetuin-A, inter-\u03b1-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes. Clin. Transl. Med. 12, e704 (2022).","journal-title":"Clin. Transl. Med."},{"key":"94725_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/reports6040045","volume":"6","author":"ST Vlasova","year":"2023","unstructured":"Vlasova, S. T., Louis, I., Fang, D., Amer, Y. & Mohei, H. COVID-19-omics report: from individual omics approaches to precision medicine. Reports 6, 45 (2023).","journal-title":"Reports"},{"key":"94725_CR21","doi-asserted-by":"publisher","first-page":"e2325914","DOI":"10.1001\/jamanetworkopen.2023.25914","volume":"6","author":"T Sood","year":"2023","unstructured":"Sood, T. et al. Biomarkers associated with severe COVID-19 among populations with high cardiometabolic risk: A 2-sample mendelian randomization study. JAMA Netw. Open 6, e2325914 (2023).","journal-title":"JAMA Netw. Open"},{"key":"94725_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/ID9.0000000000000002","volume":"1","author":"H Wang","year":"2021","unstructured":"Wang, H. Diagnosis and treatment protocol for COVID-19 patients (tentative 8th edition). Infect. Dis. Immun. 1, 8\u201316 (2021).","journal-title":"Infect. Dis. Immun."},{"key":"94725_CR23","unstructured":"World Health Organization (WHO). Country & Technical Guidance\u2014Coronavirus disease (COVID-19). https:\/\/www.who.int\/es\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance (2020)."},{"key":"94725_CR24","unstructured":"World Health Organization (WHO). WHO Hypertension Dashboard. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension (2023)."},{"key":"94725_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2021.665064","volume":"12","author":"SA Muhamad","year":"2021","unstructured":"Muhamad, S. A. et al. COVID-19 and hypertension: The what, the why, and the how. Front. Physiol. 12, 1\u201311 (2021).","journal-title":"Front. Physiol."},{"key":"94725_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17590914211057635","volume":"13","author":"HM Al-kuraishy","year":"2021","unstructured":"Al-kuraishy, H. M. et al. Covid-19-induced dysautonomia: A menace of sympathetic storm. ASN Neuro 13, 1\u201310 (2021).","journal-title":"ASN Neuro"},{"key":"94725_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.medj.2020.11.001","volume":"2","author":"SM Zekavat","year":"2021","unstructured":"Zekavat, S. M. et al. Elevated blood pressure increases pneumonia risk: epidemiological association and mendelian randomization in the UK biobank. Med 2, 137-148.e4 (2021).","journal-title":"Med"},{"key":"94725_CR28","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/CIRCRESAHA.122.320873","volume":"130","author":"S Savedchuk","year":"2022","unstructured":"Savedchuk, S., Raslan, R., Nystrom, S. & Sparks, M. A. Emerging viral infections and the potential impact on hypertension, cardiovascular disease, and kidney disease. Circ. Res. 130, 1618\u20131641 (2022).","journal-title":"Circ. Res."},{"key":"94725_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41467-022-29145-3","volume":"13","author":"T Paul","year":"2022","unstructured":"Paul, T. et al. Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19. Nat. Commun. 13, 1589 (2022).","journal-title":"Nat. Commun."},{"key":"94725_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cellsig.2024.111433","volume":"124","author":"M Paul","year":"2024","unstructured":"Paul, M., Hong, F., Falet, H. & Kim, H. Gelsolin controls the release of phosphatidylserine (PS)-positive microvesicles (MVs) from platelets. Cell. Signal. 124, 3\u20136 (2024).","journal-title":"Cell. Signal."},{"key":"94725_CR31","doi-asserted-by":"publisher","first-page":"32941","DOI":"10.1074\/jbc.M113.496802","volume":"288","author":"H Abou-Saleh","year":"2013","unstructured":"Abou-Saleh, H. et al. Inositol 1,4,5-trisphosphate (IP3) receptor up-regulation in hypertension is associated with sensitization of Ca2+ release and vascular smooth muscle contractility. J. Biol. Chem. 288, 32941\u201332951 (2013).","journal-title":"J. Biol. Chem."},{"key":"94725_CR32","doi-asserted-by":"publisher","first-page":"15280","DOI":"10.1038\/s41598-023-42293-w","volume":"13","author":"R Wawrzyniak","year":"2023","unstructured":"Wawrzyniak, R. et al. Plasma untargeted metabolomics with proteinase K discloses phospholipid signature associated with pulmonary arterial hypertension. Sci. Rep. 13, 15280 (2023).","journal-title":"Sci. Rep."},{"key":"94725_CR33","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/HJH.0000000000002363","volume":"38","author":"WJ He","year":"2020","unstructured":"He, W. J. et al. An untargeted metabolomics study of blood pressure: Findings from the Bogalusa heart study. J. Hypertens. 38, 1302\u20131311 (2020).","journal-title":"J. Hypertens."},{"key":"94725_CR34","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.3390\/jcm12247524","volume":"12","author":"M Shoghli","year":"2023","unstructured":"Shoghli, M. et al. The novel ceramide- and phosphatidylcholine-based risk score for the prediction of new-onset of hypertension. J. Clin. Med. 12, 7524 (2023).","journal-title":"J. Clin. Med."},{"key":"94725_CR35","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.1038\/s41598-021-88130-w","volume":"11","author":"B Thakur","year":"2021","unstructured":"Thakur, B. et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci. Rep. 11, 8562 (2021).","journal-title":"Sci. Rep."},{"key":"94725_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40292-022-00506-9","volume":"29","author":"G Gallo","year":"2022","unstructured":"Gallo, G., Calvez, V. & Savoia, C. Hypertension and COVID-19: Current evidence and perspectives. High Blood Press. Cardiovasc. Prev. 29, 115\u2013123 (2022).","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"94725_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","volume":"39","author":"S Trump","year":"2021","unstructured":"Trump, S. et al. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat. Biotechnol. 39, 705\u2013716 (2021).","journal-title":"Nat. Biotechnol."},{"key":"94725_CR38","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2666-5247(23)00041-1","volume":"4","author":"JF Bermejo-Martin","year":"2023","unstructured":"Bermejo-Martin, J. F. et al. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study. Lancet Microbe 4, e431\u2013e441 (2023).","journal-title":"Lancet Microbe"},{"key":"94725_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000513400","volume":"67","author":"J Hu","year":"2021","unstructured":"Hu, J. & Wang, Y. The clinical characteristics and risk factors of severe COVID-19. Gerontology 67, 255\u2013266 (2021).","journal-title":"Gerontology"},{"key":"94725_CR40","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jiac.2021.07.022","volume":"27","author":"L Chuang","year":"2021","unstructured":"Chuang, L. & Tambyah, P. A. Catheter-associated urinary tract infection. J. Infect. Chemother. 27, 1400\u20131406 (2021).","journal-title":"J. Infect. Chemother."},{"key":"94725_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12016-017-8648-x","volume":"56","author":"S Jaillon","year":"2019","unstructured":"Jaillon, S., Berthenet, K. & Garlanda, C. Sexual dimorphism in innate immunity. Clin. Rev. Allergy Immunol. 56, 308\u2013321 (2019).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"94725_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"94725_CR43","doi-asserted-by":"publisher","first-page":"105264","DOI":"10.1016\/j.ebiom.2024.105264","volume":"107","author":"AC Pouleur","year":"2024","unstructured":"Pouleur, A. C. et al. Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project. eBioMedicine 107, 105264 (2024).","journal-title":"eBioMedicine"},{"key":"94725_CR44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","volume":"44","author":"RM Touyz","year":"2004","unstructured":"Touyz, R. M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance?. Hypertension 44, 248\u2013252 (2004).","journal-title":"Hypertension"},{"key":"94725_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1081\/CEH-200031904","volume":"26","author":"J De Champlain","year":"2004","unstructured":"De Champlain, J. et al. Oxidative stress in hypertension. Clin. Exp. Hypertens. 26, 593\u2013601 (2004).","journal-title":"Clin. Exp. Hypertens."},{"key":"94725_CR46","doi-asserted-by":"publisher","first-page":"899198","DOI":"10.3389\/fphar.2022.899198","volume":"13","author":"C Vollbracht","year":"2022","unstructured":"Vollbracht, C. & Kraft, K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: Implications for the benefit of high-dose intravenous vitamin C. Front. Pharmacol. 13, 899198 (2022).","journal-title":"Front. Pharmacol."},{"key":"94725_CR47","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","volume":"95","author":"ML Croze","year":"2013","unstructured":"Croze, M. L. & Soulage, C. O. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95, 1811\u20131827 (2013).","journal-title":"Biochimie"},{"key":"94725_CR48","doi-asserted-by":"publisher","first-page":"e001989","DOI":"10.1136\/openhrt-2022-001989","volume":"9","author":"JJ DiNicolantonio","year":"2022","unstructured":"DiNicolantonio, J. J. & H O\u2019Keefe, J. Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open Hear. 9, e001989 (2022).","journal-title":"Open Hear."},{"key":"94725_CR49","doi-asserted-by":"publisher","first-page":"788687","DOI":"10.3389\/fmed.2021.788687","volume":"8","author":"MA Elrayess","year":"2022","unstructured":"Elrayess, M. A. et al. Metabolic signatures of type 2 diabetes mellitus and hypertension in COVID-19 patients with different disease severity. Front. Med. 8, 788687 (2022).","journal-title":"Front. Med."},{"key":"94725_CR50","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN van der Veen","year":"2017","unstructured":"van der Veen, J. N. et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta Biomembr. 1859, 1558\u20131572 (2017).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"94725_CR51","doi-asserted-by":"publisher","first-page":"100129","DOI":"10.1016\/j.jlr.2021.100129","volume":"62","author":"KN Theken","year":"2021","unstructured":"Theken, K. N., Tang, S. Y., Sengupta, S. & FitzGerald, G. A. The roles of lipids in SARS-CoV-2 viral replication and the host immune response. J. Lipid Res. 62, 100129 (2021).","journal-title":"J. Lipid Res."},{"key":"94725_CR52","doi-asserted-by":"publisher","first-page":"13280","DOI":"10.3390\/ijerph192013280","volume":"19","author":"M Wrona","year":"2022","unstructured":"Wrona, M. & Skrypnik, D. New-onset diabetes mellitus, hypertension, dyslipidaemia as sequelae of COVID-19 infection\u2014Systematic review. Int. J. Environ. Res. Public Health 19, 13280 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"94725_CR53","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1096\/fj.202001451","volume":"34","author":"AV Sorokin","year":"2020","unstructured":"Sorokin, A. V. et al. COVID-19\u2014Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 34, 9843\u20139853 (2020).","journal-title":"FASEB J."},{"key":"94725_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/v13010090","volume":"13","author":"JE Tanner","year":"2021","unstructured":"Tanner, J. E. & Alfieri, C. The fatty acid lipid metabolism nexus in COVID-19. Viruses 13, 90 (2021).","journal-title":"Viruses"},{"key":"94725_CR55","first-page":"1","volume":"20","author":"J Feldt","year":"2019","unstructured":"Feldt, J. et al. Structure, regulation and related diseases of the actin-binding protein gelsolin. Expert Rev. Mol. Med. 20, 1\u201310 (2019).","journal-title":"Expert Rev. Mol. Med."},{"key":"94725_CR56","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3390\/ijms19092516","volume":"19","author":"E Piktel","year":"2018","unstructured":"Piktel, E., Levental, I., Durna\u015b, B., Janmey, P. A. & Bucki, R. Plasma gelsolin: Indicator of inflammation and its potential as a diagnostic tool and therapeutic target. Int. J. Mol. Sci. 19, 2516 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"94725_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-5956-7-8","volume":"7","author":"J Wiederin","year":"2009","unstructured":"Wiederin, J., Rozek, W., Duan, F. & Ciborowski, P. Biomarkers of HIV-1 associated dementia: Proteomic investigation of sera. Proteome Sci. 7, 1\u201312 (2009).","journal-title":"Proteome Sci."},{"key":"94725_CR58","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/med.20231","volume":"32","author":"GH Li","year":"2012","unstructured":"Li, G. H., Arora, P. D., Chen, Y., Mcculloch, C. A. & Liu, P. Multifunctional roles of gelsolin in health and diseases. Med. Res. Rev. 32, 999\u20131025 (2012).","journal-title":"Med. Res. Rev."},{"key":"94725_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11010-014-1977-7","volume":"390","author":"WS Hu","year":"2014","unstructured":"Hu, W. S. et al. Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation. Mol. Cell. Biochem. 390, 263\u2013270 (2014).","journal-title":"Mol. Cell. Biochem."},{"key":"94725_CR60","doi-asserted-by":"publisher","first-page":"e12642","DOI":"10.1002\/rth2.12642","volume":"6","author":"Y Zaid","year":"2022","unstructured":"Zaid, Y. & Guessous, F. The ongoing enigma of SARS-CoV-2 and platelet interaction. Res. Pract. Thromb. Haemost. 6, e12642 (2022).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"94725_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12964-022-00856-w","volume":"20","author":"RN Mohammed","year":"2022","unstructured":"Mohammed, R. N. et al. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Commun. Signal. 20, 79 (2022).","journal-title":"Cell Commun. Signal."},{"key":"94725_CR62","doi-asserted-by":"publisher","first-page":"pbae015","DOI":"10.1093\/pcmedi\/pbae015","volume":"7","author":"ZY Guo","year":"2024","unstructured":"Guo, Z. Y. et al. COVID-19: from immune response to clinical intervention. Precis. Clin. Med. 7, pbae015 (2024).","journal-title":"Precis. Clin. Med."},{"key":"94725_CR63","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/thoraxjnl-2020-216243","volume":"76","author":"J Loo","year":"2021","unstructured":"Loo, J., Spittle, D. A. & Newnham, M. COVID-19, immunothrombosis and venous thromboembolism: Biological mechanisms. Thorax 76, 412\u2013420 (2021).","journal-title":"Thorax"},{"key":"94725_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1179877","volume":"14","author":"L Peng","year":"2023","unstructured":"Peng, L. et al. Single-cell transcriptomic landscape of immunometabolism reveals intervention candidates of ascorbate and aldarate metabolism, fatty-acid degradation and PUFA metabolism of T-cell subsets in healthy controls, psoriasis and psoriatic arthritis. Front. Immunol. 14, 1\u201316 (2023).","journal-title":"Front. Immunol."},{"key":"94725_CR65","first-page":"1","volume":"19","author":"H Liang","year":"2024","unstructured":"Liang, H. & Song, K. Elucidating ascorbate and aldarate metabolism pathway characteristics via integration of untargeted metabolomics and transcriptomics of the kidney of high-fat diet-fed obese mice. PLoS One 19, 1\u201319 (2024).","journal-title":"PLoS One"},{"key":"94725_CR66","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/biom11121873","volume":"11","author":"UN Das","year":"2021","unstructured":"Das, U. N. Essential fatty acids and their metabolites in the pathobiology of inflammation and its resolution. Biomolecules 11, 1873 (2021).","journal-title":"Biomolecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94725-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T05:54:28Z","timestamp":1743314068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94725-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94725"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94725-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Protocols were carried out following the recommendations of the Ethical and Scientific Committees from each participating institution and were approved by the Committee for Ethical Clinical Research following the rules of Good Clinical Practice from the IISPV (079\/ 2020, CEIm IISPV). The CEIm IISPV is an independent committee made up of health and non-health professionals who supervise the correct compliance of the ethical principles governing clinical trials and research projects that are performed in our environment, specifically in their methodology, ethics, and laws. All subjects or their relatives gave written informed consent following the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"10343"}}